Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non Operating Income: 2020-2024

Historic Non Operating Income for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Dec 2024 value amounting to -$68,000.

  • Harmony Biosciences Holdings' Non Operating Income rose 14.52% to -$106,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$415,000, marking a year-over-year decrease of 1085.71%. This contributed to the annual value of -$68,000 for FY2024, which is 142.77% down from last year.
  • As of FY2024, Harmony Biosciences Holdings' Non Operating Income stood at -$68,000, which was down 142.77% from $159,000 recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' Non Operating Income registered a high of $169,000 during FY2022, and its lowest value of -$3.1 million during FY2020.
  • Its 3-year average for Non Operating Income is $86,667, with a median of $159,000 in 2023.
  • In the last 5 years, Harmony Biosciences Holdings' Non Operating Income spiked by 956.25% in 2022 and then crashed by 142.77% in 2024.
  • Over the past 5 years, Harmony Biosciences Holdings' Non Operating Income (Yearly) stood at -$3.1 million in 2020, then spiked by 100.52% to $16,000 in 2021, then spiked by 956.25% to $169,000 in 2022, then declined by 5.92% to $159,000 in 2023, then crashed by 142.77% to -$68,000 in 2024.